BBIO
BRIDGEBIO PHARMA (BBIO)
NASDAQ
$79.98+$0.44 (+0.55%)
Price as of Nov 12, 2026 8:53 AM EST
  • $15.5B
    Market Cap
  • 20.11%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 50
Valuation
BBIO
vs History
vs S&P 500
Profitability
-0
Growth
0
Low Earnings Volatility
0

Momentum Score

Score: 34
Valuation
BBIO
vs History
vs S&P 500
3-Month Momentum
-24.37%
12-Month Momentum
-4.93%
3-Month Risk Adjusted Momentum
-188.78%
12-Month Risk Adjusted Momentum
-11.62%

True Yield

N/A
Valuation
BBIO
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
1.96%
Net Debt Paydown Yield
-0.003%

Financial Health Score

Score: 100
Valuation
BBIO
vs History
vs S&P 500
Ohlson's O-Score
7